Abdellatif, M; Vasques-Nóvoa, F; Trummer-Herbst, V; Durand, S; Koser, F; Islam, M; Nah, J; Sung, EA; Feng, R; Aprahamian, F; Prokesch, A; Zardoya-Laguardia, P; Sadoshima, J; Diwan, A; Linke, WA; Ferreira, JP; Kroemer, G; Sedej, S.
Autophagy is required for the therapeutic effects of the NAD+ precursor nicotinamide in obesity-related heart failure with preserved ejection fraction.
Eur Heart J. 2025;
Doi: 10.1093/eurheartj/ehaf062
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG